Basic Information
Gene Structure
upstream:
Get Sequence
Domain
| Database | EntryID | E-Value | Start | end | InterPro ID | Description |
|---|
Regulation&Interaction
Annotation
Orthologous Group
| Orthologous ID | Species Number | All hits in PereRegDB | Hits of this species | Orthologous Detail |
|---|
Expression Profile
| DataSet | Number of Samples expressed(TPM>1) | Mean | Min | Max | Standard deviation(SD) | Coeffcient variation(CV) |
|---|
Pathway
| GO Term | Description | GO Category |
|---|---|---|
| GO:0000902 | cell morphogenesis | BP |
| GO:0003674 | molecular_function | MF |
| GO:0003824 | catalytic activity | MF |
| GO:0004672 | protein kinase activity | MF |
| GO:0005575 | cellular_component | CC |
| GO:0005623 | obsolete cell | CC |
| GO:0005886 | plasma membrane | CC |
| GO:0005911 | cell-cell junction | CC |
| GO:0006464 | protein modification process | BP |
| GO:0006468 | protein phosphorylation | BP |
| GO:0006793 | phosphorus metabolic process | BP |
| GO:0006796 | phosphate-containing compound metabolic process | BP |
| GO:0006807 | nitrogen compound metabolic process | BP |
| GO:0008150 | biological_process | BP |
| GO:0008152 | metabolic process | BP |
| GO:0009506 | plasmodesma | CC |
| GO:0009653 | anatomical structure morphogenesis | BP |
| GO:0009719 | response to endogenous stimulus | BP |
| GO:0009725 | response to hormone | BP |
| GO:0009741 | response to brassinosteroid | BP |
| GO:0009826 | unidimensional cell growth | BP |
| GO:0009987 | cellular process | BP |
| GO:0010033 | response to organic substance | BP |
| GO:0014070 | response to organic cyclic compound | BP |
| GO:0016020 | membrane | CC |
| GO:0016043 | cellular component organization | BP |
| GO:0016049 | cell growth | BP |
| GO:0016301 | kinase activity | MF |
| GO:0016310 | phosphorylation | BP |
| GO:0016740 | transferase activity | MF |
| GO:0016772 | transferase activity, transferring phosphorus-containing groups | MF |
| GO:0016773 | phosphotransferase activity, alcohol group as acceptor | MF |
| GO:0019538 | protein metabolic process | BP |
| GO:0030054 | cell junction | CC |
| GO:0032502 | developmental process | BP |
| GO:0032989 | cellular component morphogenesis | BP |
| GO:0033993 | response to lipid | BP |
| GO:0036211 | protein modification process | BP |
| GO:0040007 | growth | BP |
| GO:0042221 | response to chemical | BP |
| GO:0043170 | macromolecule metabolic process | BP |
| GO:0043412 | macromolecule modification | BP |
| GO:0044237 | cellular metabolic process | BP |
| GO:0044238 | primary metabolic process | BP |
| GO:0044260 | cellular macromolecule metabolic process | BP |
| GO:0044267 | protein metabolic process | BP |
| GO:0044464 | obsolete cell part | CC |
| GO:0048589 | developmental growth | BP |
| GO:0048856 | anatomical structure development | BP |
| GO:0048869 | cellular developmental process | BP |
| GO:0050896 | response to stimulus | BP |
| GO:0055044 | symplast | CC |
| GO:0060560 | developmental growth involved in morphogenesis | BP |
| GO:0071704 | organic substance metabolic process | BP |
| GO:0071840 | cellular component organization or biogenesis | BP |
| GO:0071944 | cell periphery | CC |
| GO:0140096 | catalytic activity, acting on a protein | MF |
| GO:1901564 | organonitrogen compound metabolic process | BP |
| GO:1901700 | response to oxygen-containing compound | BP |
| KEGG Term | Name | Description |
|---|---|---|
| map04626 | Plant-pathogen interaction | Plants lack animal-like adaptive immunity mechanisms, and therefore have evolved a specific system with multiple layers against invading pathogens. The primary response includes the perception of pathogens by cell-surface pattern-recognition receptors (PRRs) and is referred to as PAMP-triggered immunity (PTI). Activation of FLS2 and EFR triggers MAPK signaling pathway that activates defense genes for antimictobial compounds. The increase in the cytosolic Ca2+ concentration is also a regulator for production of reactive oxygen species and localized programmed cell death/hypersensitive response. The secondary response is called effector-triggered immunity (ETI). Pathogens can acquire the ability to suppress PTI by directly injecting effector proteins into the plant cell through secretion systems. In addition, pathogens can manipulate plant hormone signaling pathways to evade host immune responses using coronatine toxin. Some plants possess specific intracellular surveillance proteins (R proteins) to monitor the presence of pathogen virulence proteins. This ETI occurs with localized programmed cell death to arrest pathogen growth, resulting in cultivar-specific disease resistance. |

